| Ticker Details |
|
ADC Therapeutics SA
|
| IPO Date: |
May 18, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$431.18M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.36 | 3.75%
|
| Avg Daily Range (30 D): |
$0.08 | 2.22%
|
| Avg Daily Range (90 D): |
$0.10 | 2.62%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.47M |
| Avg Daily Volume (30 D): |
1.01M |
| Avg Daily Volume (90 D): |
.79M |
| Trade Size |
| Avg Trade Size (Sh.): |
138 |
| Avg Trade Size (Sh.) (30 D): |
119 |
| Avg Trade Size (Sh.) (90 D): |
110 |
| Institutional Trades |
| Total Institutional Trades: |
353 |
| Avg Institutional Trade: |
$1.36M |
| Avg Institutional Trade (30 D): |
$1.1M |
| Avg Institutional Trade (90 D): |
$1.24M |
| Avg Institutional Trade Volume: |
.2M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.96M |
| Avg Closing Trade (30 D): |
$.72M |
| Avg Closing Trade (90 D): |
$1.09M |
| Avg Closing Volume: |
445.36K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.99
|
$-.21
|
$.02
|
|
Diluted EPS
|
$-.99
|
$-.21
|
$.02
|
|
Revenue
|
$79.18M
|
$20.85M
|
$23.06M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-136.99M
|
$-32.97M
|
$-6.41M
|
|
Operating Income / Loss
|
$-118.28M
|
$-25.25M
|
$-17.92M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$36.31M
|
$-30.33M
|
$26.6M
|
|
PE Ratio
|
|
|
|
|
|
|